Cutaneous T-cell lymphoma treatment using bexarotene and PUVA: a case series
F Singh, MG Lebwohl - Journal of the American Academy of Dermatology, 2004 - Elsevier
BACKGROUND: Mycosis fungoides, the most common form of cutaneous T-cell lymphoma,
often presents as chronic eczematous or psoriasiform patches and plaques that can be
resistant to a variety of single-agent treatment modalities, necessitating combination therapy.
OBJECTIVE: To evaluate the efficacy of combination therapy with bexarotene and psoralen
plus ultraviolet A (PUVA) in treating patients with cutaneous T-cell lymphoma (CTCL) that
recurred following monotherapy with multiple agents, including electron-beam irradiation …
often presents as chronic eczematous or psoriasiform patches and plaques that can be
resistant to a variety of single-agent treatment modalities, necessitating combination therapy.
OBJECTIVE: To evaluate the efficacy of combination therapy with bexarotene and psoralen
plus ultraviolet A (PUVA) in treating patients with cutaneous T-cell lymphoma (CTCL) that
recurred following monotherapy with multiple agents, including electron-beam irradiation …